Selected research
Industry Growth & Trends
Global Leucovorin Calcium Injection Industry Growth and Trends Forecast to 2032
Market perspective
The global Leucovorin Calcium Injection market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.
The North America market for Leucovorin Calcium Injection is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.
The Europe market for Leucovorin Calcium Injection is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.
Read the full market overview
The Asia Pacific market for Leucovorin Calcium Injection is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Leading global manufacturers of Leucovorin Calcium Injection include BluePoint Laboratories, Get Well Pharmaceutical, Hikma, RMPL Pharma, Sagent, Fresenius Kabi, Mylan and Teva, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report provides a structured, data-driven view of the global Leucovorin Calcium Injection market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.
The Leucovorin Calcium Injection market size, estimates, and forecasts are presented in terms of sales volume (W Units) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Leucovorin Calcium Injection market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Leucovorin Calcium Injection.
Key Companies & Market Share Insights
This section analyzes the strategies and performance of leading manufacturers in the global Leucovorin Calcium Injection market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.
Leucovorin Calcium Injection Market by Company
BluePoint Laboratories
Get Well Pharmaceutical
Hikma
RMPL Pharma
Sagent
Fresenius Kabi
Mylan
Teva
Leucovorin Calcium Injection Segment by Type
50mg/vial
100mg/vial
200mg/vial
350mg/vial
Leucovorin Calcium Injection Segment by Application
Hospital
Clinics
Recovery Center
Leucovorin Calcium Injection Segment by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Netherlands
Nordic Countries
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
South America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Leucovorin Calcium Injection market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Leucovorin Calcium Injection and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Leucovorin Calcium Injection.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Leucovorin Calcium Injection manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Sales, revenue of Leucovorin Calcium Injection in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.
Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.
Chapter 13: Concluding Insights of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- 50mg/vial
- 100mg/vial
- 200mg/vial
- 350mg/vial
Applications
- Hospital
- Clinics
- Recovery Center
Companies covered
- BluePoint Laboratories
- Get Well Pharmaceutical
- Hikma
- RMPL Pharma
- Sagent
- Fresenius Kabi
- Mylan
- Teva
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Global Market Growth Prospects
- 1.2.1 Global Leucovorin Calcium Injection Market Size Estimates and Forecasts (2021-2032)
- 1.2.2 Global Leucovorin Calcium Injection Sales Estimates and Forecasts (2021-2032)
- 1.3 Leucovorin Calcium Injection Market by Type
- 1.3.1 50mg/vial
- 1.3.2 100mg/vial
- 1.3.3 200mg/vial
- 1.3.4 350mg/vial
- 1.4 Global Leucovorin Calcium Injection Market Size by Type
- 1.4.1 Global Leucovorin Calcium Injection Market Size Overview by Type (2021-2032)
- 1.4.2 Global Leucovorin Calcium Injection Historic Market Size Review by Type (2021-2026)
- 1.4.3 Global Leucovorin Calcium Injection Forecasted Market Size by Type (2027-2032)
- 1.5 Key Regions Market Size by Type
- 1.5.1 North America Leucovorin Calcium Injection Sales Breakdown by Type (2021-2026)
- 1.5.2 Europe Leucovorin Calcium Injection Sales Breakdown by Type (2021-2026)
- 1.5.3 Asia-Pacific Leucovorin Calcium Injection Sales Breakdown by Type (2021-2026)
- 1.5.4 South America Leucovorin Calcium Injection Sales Breakdown by Type (2021-2026)
- 1.5.5 Middle East and Africa Leucovorin Calcium Injection Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
- 2.1 Leucovorin Calcium Injection Industry Trends
- 2.2 Leucovorin Calcium Injection Industry Drivers
- 2.3 Leucovorin Calcium Injection Industry Opportunities and Challenges
- 2.4 Leucovorin Calcium Injection Industry Restraints
3 Market Competitive Landscape by Company
- 3.1 Global Top Players by Leucovorin Calcium Injection Revenue (2021-2026)
- 3.2 Global Top Players by Leucovorin Calcium Injection Sales (2021-2026)
- 3.3 Global Top Players by Leucovorin Calcium Injection Price (2021-2026)
- 3.4 Global Leucovorin Calcium Injection Industry Company Ranking, 2024 VS 2025 VS 2026
- 3.5 Global Leucovorin Calcium Injection Major Company Production Sites & Headquarters
- 3.6 Global Leucovorin Calcium Injection Company, Product Type & Application
- 3.7 Global Leucovorin Calcium Injection Company Establishment Date
- 3.8 Market Competitive Analysis
- 3.8.1 Global Leucovorin Calcium Injection Market CR5 and HHI
- 3.8.2 Global Top 5 and 10 Leucovorin Calcium Injection Players Market Share by Revenue in 2025
- 3.8.3 2025 Leucovorin Calcium Injection Tier 1, Tier 2, and Tier 3
4 Leucovorin Calcium Injection Regional Status and Outlook
- 4.1 Global Leucovorin Calcium Injection Market Size and CAGR by Region: 2021 VS 2025 VS 2032
- 4.2 Global Leucovorin Calcium Injection Historic Market Size by Region
- 4.2.1 Global Leucovorin Calcium Injection Sales in Volume by Region (2021-2026)
- 4.2.2 Global Leucovorin Calcium Injection Sales in Value by Region (2021-2026)
- 4.2.3 Global Leucovorin Calcium Injection Sales (Volume & Value), Price and Gross Margin (2021-2026)
- 4.3 Global Leucovorin Calcium Injection Forecasted Market Size by Region
- 4.3.1 Global Leucovorin Calcium Injection Sales in Volume by Region (2027-2032)
- 4.3.2 Global Leucovorin Calcium Injection Sales in Value by Region (2027-2032)
- 4.3.3 Global Leucovorin Calcium Injection Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Leucovorin Calcium Injection by Application
- 5.1 Leucovorin Calcium Injection Market by Application
- 5.1.1 Hospital
- 5.1.2 Clinics
- 5.1.3 Recovery Center
- 5.2 Global Leucovorin Calcium Injection Market Size by Application
- 5.2.1 Global Leucovorin Calcium Injection Market Size Overview by Application (2021-2032)
- 5.2.2 Global Leucovorin Calcium Injection Historic Market Size Review by Application (2021-2026)
- 5.2.3 Global Leucovorin Calcium Injection Forecasted Market Size by Application (2027-2032)
- 5.3 Key Regions Market Size by Application
- 5.3.1 North America Leucovorin Calcium Injection Sales Breakdown by Application (2021-2026)
- 5.3.2 Europe Leucovorin Calcium Injection Sales Breakdown by Application (2021-2026)
- 5.3.3 Asia-Pacific Leucovorin Calcium Injection Sales Breakdown by Application (2021-2026)
- 5.3.4 South America Leucovorin Calcium Injection Sales Breakdown by Application (2021-2026)
- 5.3.5 Middle East and Africa Leucovorin Calcium Injection Sales Breakdown by Application (2021-2026)
6 Company Profiles
- 6.1 BluePoint Laboratories
- 6.1.1 BluePoint Laboratories Company Information
- 6.1.2 BluePoint Laboratories Business Overview
- 6.1.3 BluePoint Laboratories Leucovorin Calcium Injection Sales, Revenue and Gross Margin (2021-2026)
- 6.1.4 BluePoint Laboratories Leucovorin Calcium Injection Product Portfolio
- 6.1.5 BluePoint Laboratories Recent Developments
- 6.2 Get Well Pharmaceutical
- 6.2.1 Get Well Pharmaceutical Company Information
- 6.2.2 Get Well Pharmaceutical Business Overview
- 6.2.3 Get Well Pharmaceutical Leucovorin Calcium Injection Sales, Revenue and Gross Margin (2021-2026)
- 6.2.4 Get Well Pharmaceutical Leucovorin Calcium Injection Product Portfolio
- 6.2.5 Get Well Pharmaceutical Recent Developments
- 6.3 Hikma
- 6.3.1 Hikma Company Information
- 6.3.2 Hikma Business Overview
- 6.3.3 Hikma Leucovorin Calcium Injection Sales, Revenue and Gross Margin (2021-2026)
- 6.3.4 Hikma Leucovorin Calcium Injection Product Portfolio
- 6.3.5 Hikma Recent Developments
- 6.4 RMPL Pharma
- 6.4.1 RMPL Pharma Company Information
- 6.4.2 RMPL Pharma Business Overview
- 6.4.3 RMPL Pharma Leucovorin Calcium Injection Sales, Revenue and Gross Margin (2021-2026)
- 6.4.4 RMPL Pharma Leucovorin Calcium Injection Product Portfolio
- 6.4.5 RMPL Pharma Recent Developments
- 6.5 Sagent
- 6.5.1 Sagent Company Information
- 6.5.2 Sagent Business Overview
- 6.5.3 Sagent Leucovorin Calcium Injection Sales, Revenue and Gross Margin (2021-2026)
- 6.5.4 Sagent Leucovorin Calcium Injection Product Portfolio
- 6.5.5 Sagent Recent Developments
- 6.6 Fresenius Kabi
- 6.6.1 Fresenius Kabi Company Information
- 6.6.2 Fresenius Kabi Business Overview
- 6.6.3 Fresenius Kabi Leucovorin Calcium Injection Sales, Revenue and Gross Margin (2021-2026)
- 6.6.4 Fresenius Kabi Leucovorin Calcium Injection Product Portfolio
- 6.6.5 Fresenius Kabi Recent Developments
- 6.7 Mylan
- 6.7.1 Mylan Company Information
- 6.7.2 Mylan Business Overview
- 6.7.3 Mylan Leucovorin Calcium Injection Sales, Revenue and Gross Margin (2021-2026)
- 6.7.4 Mylan Leucovorin Calcium Injection Product Portfolio
- 6.7.5 Mylan Recent Developments
- 6.8 Teva
- 6.8.1 Teva Company Information
- 6.8.2 Teva Business Overview
- 6.8.3 Teva Leucovorin Calcium Injection Sales, Revenue and Gross Margin (2021-2026)
- 6.8.4 Teva Leucovorin Calcium Injection Product Portfolio
- 6.8.5 Teva Recent Developments
7 North America by Country
- 7.1 North America Leucovorin Calcium Injection Sales by Country
- 7.1.1 North America Leucovorin Calcium Injection Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 7.1.2 North America Leucovorin Calcium Injection Sales by Country (2021-2026)
- 7.1.3 North America Leucovorin Calcium Injection Sales Forecast by Country (2027-2032)
- 7.2 North America Leucovorin Calcium Injection Market Size by Country
- 7.2.1 North America Leucovorin Calcium Injection Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 7.2.2 North America Leucovorin Calcium Injection Market Size by Country (2021-2026)
- 7.2.3 North America Leucovorin Calcium Injection Market Size Forecast by Country (2027-2032)
8 Europe by Country
- 8.1 Europe Leucovorin Calcium Injection Sales by Country
- 8.1.1 Europe Leucovorin Calcium Injection Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 8.1.2 Europe Leucovorin Calcium Injection Sales by Country (2021-2026)
- 8.1.3 Europe Leucovorin Calcium Injection Sales Forecast by Country (2027-2032)
- 8.2 Europe Leucovorin Calcium Injection Market Size by Country
- 8.2.1 Europe Leucovorin Calcium Injection Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 8.2.2 Europe Leucovorin Calcium Injection Market Size by Country (2021-2026)
- 8.2.3 Europe Leucovorin Calcium Injection Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
- 9.1 Asia-Pacific Leucovorin Calcium Injection Sales by Country
- 9.1.1 Asia-Pacific Leucovorin Calcium Injection Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 9.1.2 Asia-Pacific Leucovorin Calcium Injection Sales by Country (2021-2026)
- 9.1.3 Asia-Pacific Leucovorin Calcium Injection Sales Forecast by Country (2027-2032)
- 9.2 Asia-Pacific Leucovorin Calcium Injection Market Size by Country
- 9.2.1 Asia-Pacific Leucovorin Calcium Injection Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 9.2.2 Asia-Pacific Leucovorin Calcium Injection Market Size by Country (2021-2026)
- 9.2.3 Asia-Pacific Leucovorin Calcium Injection Market Size Forecast by Country (2027-2032)
10 South America by Country
- 10.1 South America Leucovorin Calcium Injection Sales by Country
- 10.1.1 South America Leucovorin Calcium Injection Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 10.1.2 South America Leucovorin Calcium Injection Sales by Country (2021-2026)
- 10.1.3 South America Leucovorin Calcium Injection Sales Forecast by Country (2027-2032)
- 10.2 South America Leucovorin Calcium Injection Market Size by Country
- 10.2.1 South America Leucovorin Calcium Injection Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 10.2.2 South America Leucovorin Calcium Injection Market Size by Country (2021-2026)
- 10.2.3 South America Leucovorin Calcium Injection Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
- 11.1 Middle East and Africa Leucovorin Calcium Injection Sales by Country
- 11.1.1 Middle East and Africa Leucovorin Calcium Injection Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 11.1.2 Middle East and Africa Leucovorin Calcium Injection Sales by Country (2021-2026)
- 11.1.3 Middle East and Africa Leucovorin Calcium Injection Sales Forecast by Country (2027-2032)
- 11.2 Middle East and Africa Leucovorin Calcium Injection Market Size by Country
- 11.2.1 Middle East and Africa Leucovorin Calcium Injection Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 11.2.2 Middle East and Africa Leucovorin Calcium Injection Market Size by Country (2021-2026)
- 11.2.3 Middle East and Africa Leucovorin Calcium Injection Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
- 12.1 Leucovorin Calcium Injection Value Chain Analysis
- 12.1.1 Leucovorin Calcium Injection Key Raw Materials
- 12.1.2 Key Raw Materials Price
- 12.1.3 Raw Materials Key Suppliers
- 12.1.4 Manufacturing Cost Structure
- 12.1.5 Leucovorin Calcium Injection Production Mode & Process
- 12.2 Leucovorin Calcium Injection Sales Channels Analysis
- 12.2.1 Direct Comparison with Distribution Share
- 12.2.2 Leucovorin Calcium Injection Distributors
- 12.2.3 Leucovorin Calcium Injection Customers
13 Concluding Insights
14 Appendix
- 14.1 Reasons for Doing This Study
- 14.2 Research Methodology
- 14.3 Research Process
- 14.4 Authors List of This Report
- 14.5 Data Source
- 14.5.1 Secondary Sources
- 14.5.2 Primary Sources
- 14.6 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst